BioStem Technologies, Inc.
BSEM
$3.71
$0.102.77%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -8.97M | -8.82M | -11.26M | 761.10K | 10.60K |
| Total Depreciation and Amortization | 744.20K | 592.30K | 98.00K | 114.70K | 90.20K |
| Total Amortization of Deferred Charges | -- | -- | 0.00 | 0.00 | 25.40K |
| Total Other Non-Cash Items | 2.96M | 1.55M | 14.27M | 1.44M | 2.39M |
| Change in Net Operating Assets | -271.60K | 5.85M | -281.30K | -4.70M | 2.91M |
| Cash from Operations | -5.54M | -825.50K | 2.83M | -2.38M | 5.42M |
| Capital Expenditure | -56.10K | -1.80K | -436.80K | -2.42M | -332.40K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 0.00 | -15.02M | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 0.00 | 1.25M | -- |
| Cash from Investing | -56.10K | -15.02M | -436.80K | -1.17M | -332.40K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -3.50M | -- | 0.00 | -150.00K | -919.60K |
| Issuance of Common Stock | 2.50M | -- | 0.00 | 15.00K | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -146.30K | -- | -- | -- | -- |
| Cash from Financing | -1.15M | -- | 0.00 | -135.00K | -919.60K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | 0.00 | -- | -- |
| Net Change in Cash | -6.74M | -15.85M | 2.39M | -3.69M | 4.17M |